Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptor 5 (TLR5) is a transmembrane pattern-recognition receptor (PRR) that plays a critical role in the innate immune system by detecting bacterial flagellin, the primary protein component of bacterial flagella. It is expressed on various cells, including macrophages, dendritic cells, and intestinal epithelial cells, where it serves as a sentinel for motile bacterial pathogens. Upon flagellin binding, TLR5 dimerizes and recruits the MyD88 adapter protein, triggering a signaling cascade that activates the NF-κB transcription factor and induces the expression of pro-inflammatory cytokines and chemokines. In addition to extracellular recognition by TLR5, intracellular flagellin can be detected by the NLRC4 inflammasome via NAIP proteins, leading to caspase-1 activation and pyroptosis.
Therapeutically, TLR5 is a significant target for drug development, particularly as a site for vaccine adjuvants and radioprotectants. Agonists like Entolimod (CBLB502) have demonstrated the ability to protect hematopoietic and gastrointestinal tissues from lethal doses of radiation by activating NF-κB-mediated anti-apoptotic pathways. However, the therapeutic use of TLR5 modulators must be carefully managed due to the risk of systemic inflammatory responses or cytokine storms. Furthermore, while TLR5 activation can stimulate anti-tumor immunity, its role in cancer is complex, as it may also promote tumor progression in certain environments, such as the gut.
TLR5 agonism activates the MyD88/NF-κB pathway to induce cytokines and survival signals; NLRC4 activation triggers the inflammasome and caspase-1.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 5 (TLR5) (TLR5).